ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 201 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2020. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,669,935 | +8.0% | 2,333,805 | +3.5% | 0.00% | +33.3% |
| Q2 2023 | $28,404,175 | -0.5% | 2,254,299 | +3.1% | 0.00% | -25.0% |
| Q1 2023 | $28,543,399 | +77219.9% | 2,187,233 | +4.5% | 0.00% | -20.0% |
| Q4 2022 | $36,916 | -99.9% | 2,092,792 | +1.6% | 0.01% | 0.0% |
| Q3 2022 | $31,369,000 | -2.6% | 2,059,686 | -5.2% | 0.01% | 0.0% |
| Q2 2022 | $32,220,000 | -37.6% | 2,172,646 | -5.2% | 0.01% | -16.7% |
| Q1 2022 | $51,613,000 | +20.5% | 2,291,912 | -1.3% | 0.01% | +20.0% |
| Q4 2021 | $42,831,000 | +25.3% | 2,321,485 | -9.2% | 0.01% | 0.0% |
| Q3 2021 | $34,175,000 | -35.6% | 2,556,141 | -10.9% | 0.01% | -28.6% |
| Q2 2021 | $53,088,000 | +21.5% | 2,868,108 | -1.5% | 0.01% | 0.0% |
| Q1 2021 | $43,700,000 | +7.6% | 2,910,477 | +3.5% | 0.01% | 0.0% |
| Q4 2020 | $40,612,000 | +75.6% | 2,812,531 | -1.0% | 0.01% | +40.0% |
| Q3 2020 | $23,121,000 | +22.6% | 2,840,473 | +2.0% | 0.01% | +25.0% |
| Q2 2020 | $18,860,000 | -8.1% | 2,785,891 | -4.4% | 0.00% | -20.0% |
| Q1 2020 | $20,522,000 | -63.1% | 2,915,113 | -48.6% | 0.01% | -16.7% |
| Q4 2019 | $55,640,000 | +84.2% | 5,669,016 | +106.1% | 0.01% | -14.3% |
| Q3 2019 | $30,199,000 | -2.7% | 2,750,416 | +3.1% | 0.01% | -12.5% |
| Q2 2019 | $31,022,000 | +25.4% | 2,667,436 | +2.9% | 0.01% | +33.3% |
| Q1 2019 | $24,737,000 | -49.0% | 2,593,005 | -48.4% | 0.01% | -14.3% |
| Q4 2018 | $48,468,000 | +44.9% | 5,027,974 | +114.3% | 0.01% | -22.2% |
| Q3 2018 | $33,438,000 | +34.4% | 2,346,557 | +13.2% | 0.01% | +12.5% |
| Q2 2018 | $24,873,000 | +3.8% | 2,072,775 | +6.9% | 0.01% | 0.0% |
| Q1 2018 | $23,954,000 | -14.0% | 1,939,673 | +1.4% | 0.01% | -11.1% |
| Q4 2017 | $27,844,000 | +20.9% | 1,913,696 | +18.2% | 0.01% | 0.0% |
| Q3 2017 | $23,034,000 | +13.6% | 1,618,703 | +1.9% | 0.01% | +12.5% |
| Q2 2017 | $20,277,000 | +2.2% | 1,589,121 | +1.6% | 0.01% | 0.0% |
| Q1 2017 | $19,832,000 | +36.1% | 1,564,055 | +9.6% | 0.01% | +14.3% |
| Q4 2016 | $14,570,000 | -15.6% | 1,427,207 | +8.9% | 0.01% | -22.2% |
| Q3 2016 | $17,256,000 | +8.3% | 1,310,316 | +4.4% | 0.01% | 0.0% |
| Q2 2016 | $15,936,000 | -1.0% | 1,254,887 | +3.0% | 0.01% | 0.0% |
| Q1 2016 | $16,098,000 | -9.0% | 1,218,747 | +6.0% | 0.01% | -10.0% |
| Q4 2015 | $17,683,000 | +36.8% | 1,149,792 | +10.3% | 0.01% | +25.0% |
| Q3 2015 | $12,922,000 | -6.0% | 1,042,141 | +3.7% | 0.01% | 0.0% |
| Q2 2015 | $13,741,000 | +19.2% | 1,004,489 | +4.2% | 0.01% | +14.3% |
| Q1 2015 | $11,528,000 | +0.2% | 963,935 | +7.0% | 0.01% | 0.0% |
| Q4 2014 | $11,504,000 | +1.1% | 900,932 | +6.2% | 0.01% | 0.0% |
| Q3 2014 | $11,381,000 | -15.6% | 848,399 | +1.0% | 0.01% | -22.2% |
| Q2 2014 | $13,481,000 | -11.1% | 839,965 | -0.1% | 0.01% | -10.0% |
| Q1 2014 | $15,161,000 | +20.2% | 840,891 | +3.0% | 0.01% | +11.1% |
| Q4 2013 | $12,618,000 | +21.7% | 816,176 | +17.1% | 0.01% | +12.5% |
| Q3 2013 | $10,368,000 | +15.5% | 697,212 | +0.5% | 0.01% | 0.0% |
| Q2 2013 | $8,980,000 | – | 693,978 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |